Hans-Joachim Lankau

This inventor holds 14 USPTO granted patents and 3 published patent applications, plus 3 CIPO patents and 5 EPO patents. Top assignees: Arzneimittelwerk Dresden Gmbh, Janssen Pharmaceuticals, Inc., Boehringer Ingelheim Vetmedica Gmbh. Active years: 1998-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hans-Joachim Lankau. Retrieved from https://idiyas.com/inventor/hans-joachim-lankau

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 (Patent Applications = 3)

% Patents Active = 92.9

CIPO Patents = 3 (Patent Applications = 3)

EPO Patents = 5 (Patent Applications = 8)

Average Co-Inventor Count = 6.5

ph-index = 6

Forward Citations = 73(Granted Patents)

Location History:

Dresden, DE (1998 - 1999)
Einböhla, DE (2002)
Weinbohla, DE (2000 - 2016)
Weinboehla, DE (2017)
Weinböhla, DE (2015 - 2023)

Company Filing History:

4 out of 39

Arzneimittelwerk Dresden Gmbh

patents

4 out of 161

Janssen Pharmaceuticals, Inc.

patents

3 out of 317

Boehringer Ingelheim Vetmedica Gmbh

patents

4. 2 out of 1,562

Boehringer Ingelheim International Gmbh

patents

5. 1 out of 1

Arzneitmittelwerk Dresden G.m.b.h.

patent

Years Active: 1998-2023

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. RE49517 - Pyrazoles (2023-05-01),

2. 10323021 - Triazoles as NR2B receptor inhibitors (2019-06-18),

3. 10155727 - Pyrazoles (2018-12-18),

4. 9981950 - Triazoles as NR2B receptor inhibitors (2018-05-29),

5. 9540379 - (1,2,4)triazolo[4,3-A]quinoxaline derivatives as inhibitors of phosphodiesterases (2017-01-10),

6. 9469611 - Use of dihydroimidazolones for the treatment of dogs (2016-10-18),

7. 9085584 - Substituted pyrido[3,2-E][1,2,4]-triazolo[4,3-A]pyrazines for the treatment of central nervous system disorders (2015-07-21),

8. 8962617 - Use of dihydroimidazolones for the treatment of dogs (2015-02-24),

9. 8859540 - Use of dihydroimidazolones for the treatment of dogs (2014-10-14),

10. 6500821 - 4-amino-1-aryl-1,5-dihydropyrrol-2-ones and process for making (2002-12-31),

11. 6071911 - 4-amino-1-arylpyridin-2-ones and process for making (2000-06-06),

12. 6054460 - Anticonvulsive and antiallergic/antiasthmatic (2000-04-25),

13. 5869481 - Anticonvulsive 1-ar(alk)ylimidazolin-2-ones and process for making (1999-02-09),

14. 5817685 - Anticonvulsive imidazoline-2,4-diones and process for making (1998-10-06),

Title: The Innovative Journey of Hans-Joachim Lankau

Introduction: Hans-Joachim Lankau, a distinguished inventor hailing from Weinböhla, Germany, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Lankau's latest patents showcase his commitment to innovation, with a focus on advancements in renewable energy technologies and sustainable solutions for environmental challenges.

Career Highlights: Throughout his illustrious career, Lankau has been at the forefront of technological innovation, leading research and development teams to create cutting-edge solutions in the fields of clean energy, automation, and digital transformation.

Collaborations: Lankau has collaborated with leading research institutions, universities, and multinational companies to bring his inventions to life, fostering a culture of creativity and excellence in the tech industry.

Conclusion: Hans-Joachim Lankau's passion for innovation and his relentless pursuit of technological advancement have solidified his reputation as a visionary inventor, shaping the future of technology for generations to come.

Profile summary based on public USPTO records.